N. Kreischer

Statistics

Publications

Citations

615

H-Index

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

N. Kreischer is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, poly adp-ribose polymerase inhibitors, and poly(adp-ribose) polymerase inhibition.

Publications per year

2011–2013

Publications

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen Sandhu, William R. Schelman, George Wilding et al. · The Lancet Oncology · 2013 · 558 citations

Medicine, Oncology, Pharmacology +12

First-in-human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients with antitumor activity in BRCA-deficient tumors and sporadic ovarian cancers (soc).

William R. Schelman, Shahneen Sandhu, G. Wilding et al. · Journal of Clinical Oncology · 2011 · 57 citations

Medicine, Oncology, Pharmacology +15

1–2 of 2